Benjamin T Dake Aerovate Therapeutics, Inc. (AVTE) insider trading activity

Benjamin T Dake is of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 14,252 shares of AVTE, which is worth approximately $38,195. The most recent transaction as insider was on Aug 01, 2024, when has been sold 1,507 shares (Common Stock) at a price of $1.74 per share, resulting in proceeds of $2,622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K

0% 3M change

0% 12M change

Total Value Held $38,195

Benjamin T Dake Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	BUY Exercise of conversion of derivative security	$2,622 $1.74 p/Share	1,507 Added 9.56%	14,252 Common Stock
Jul 31 2024	BUY Exercise of conversion of derivative security	$19,929 $1.74 p/Share	11,454 Added 47.33%	12,745 Common Stock
Apr 17 2024	SELL Open market or private sale	$158,646 $23.15 p/Share	6,853 Reduced 84.15%	1,291 Common Stock
Apr 17 2024	BUY Exercise of conversion of derivative security	$14,665 $2.14 p/Share	6,853 Added 45.7%	8,144 Common Stock
Apr 01 2024	SELL Open market or private sale	$106,300 $31.97 p/Share	3,325 Reduced 72.03%	1,291 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$35,278 $10.61 p/Share	3,325 Added 41.87%	4,616 Common Stock
Mar 27 2024	SELL Open market or private sale	$309,571 $27.97 p/Share	11,068 Reduced 89.55%	1,291 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	$117,431 $10.61 p/Share	11,068 Added 47.24%	12,359 Common Stock
Mar 25 2024	SELL Open market or private sale	$96,130 $28.01 p/Share	3,432 Reduced 72.67%	1,291 Common Stock
Mar 25 2024	BUY Exercise of conversion of derivative security	$36,413 $10.61 p/Share	3,432 Added 42.08%	4,723 Common Stock
Mar 18 2024	SELL Open market or private sale	$915,338 $26.11 p/Share	35,057 Reduced 96.45%	1,291 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	$223,663 $6.38 p/Share	35,057 Added 49.1%	36,348 Common Stock
Dec 06 2023	SELL Open market or private sale	$165,659 $16.11 p/Share	10,283 Reduced 88.85%	1,291 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$19,949 $1.94 p/Share	10,283 Added 47.05%	11,574 Common Stock
Nov 27 2023	SELL Open market or private sale	$203,276 $16.24 p/Share	12,517 Reduced 90.65%	1,291 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	$24,282 $1.94 p/Share	12,517 Added 47.55%	13,808 Common Stock
Nov 24 2023	SELL Open market or private sale	$79,390 $15.91 p/Share	4,990 Reduced 79.45%	1,291 Common Stock
Nov 24 2023	BUY Exercise of conversion of derivative security	$10,678 $2.14 p/Share	4,990 Added 44.27%	6,281 Common Stock
Nov 22 2023	SELL Open market or private sale	$142,324 $15.17 p/Share	9,382 Reduced 87.9%	1,291 Common Stock
Nov 22 2023	BUY Exercise of conversion of derivative security	$18,201 $1.94 p/Share	9,382 Added 46.78%	10,673 Common Stock
Sep 07 2023	SELL Open market or private sale	$450 $15.01 p/Share	30 Reduced 2.27%	1,291 Common Stock
Sep 07 2023	BUY Exercise of conversion of derivative security	$64 $2.14 p/Share	30 Added 2.22%	1,321 Common Stock
Sep 06 2023	SELL Open market or private sale	$59,200 $15.06 p/Share	3,931 Reduced 75.28%	1,291 Common Stock
Sep 06 2023	BUY Exercise of conversion of derivative security	$7,626 $1.94 p/Share	3,931 Added 42.95%	5,222 Common Stock
Aug 07 2023	SELL Open market or private sale	$163,191 $15.87 p/Share	10,283 Reduced 88.85%	1,291 Common Stock

BTD

Benjamin T Dake

Waltham,, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Value

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE

Account